These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 28937306)
21. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release. Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917 [TBL] [Abstract][Full Text] [Related]
22. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles. Yan Y; Fu J; Wang T; Lu X Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940 [TBL] [Abstract][Full Text] [Related]
23. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. Zhao Y; Sun X; Zhang G; Trewyn BG; Slowing II; Lin VS ACS Nano; 2011 Feb; 5(2):1366-75. PubMed ID: 21294526 [TBL] [Abstract][Full Text] [Related]
24. Biocompatibility, cytotoxicity and antibacterial effects of meropenem-loaded mesoporous silica nanoparticles against carbapenem-resistant Memar MY; Yekani M; Ghanbari H; Shahi S; Sharifi S; Maleki Dizaj S Artif Cells Nanomed Biotechnol; 2020 Nov; 48(1):1354-1361. PubMed ID: 33236938 [TBL] [Abstract][Full Text] [Related]
25. Amine modification of nonporous silica nanoparticles reduces inflammatory response following intratracheal instillation in murine lungs. Morris AS; Adamcakova-Dodd A; Lehman SE; Wongrakpanich A; Thorne PS; Larsen SC; Salem AK Toxicol Lett; 2016 Jan; 241():207-15. PubMed ID: 26562768 [TBL] [Abstract][Full Text] [Related]
27. Unique Biological Degradation Behavior of Stöber Mesoporous Silica Nanoparticles from Their Interiors to Their Exteriors. Chen G; Teng Z; Su X; Liu Y; Lu G J Biomed Nanotechnol; 2015 Apr; 11(4):722-9. PubMed ID: 26310078 [TBL] [Abstract][Full Text] [Related]
28. Biocompatibility of mesoporous silica nanoparticles. Asefa T; Tao Z Chem Res Toxicol; 2012 Nov; 25(11):2265-84. PubMed ID: 22823891 [TBL] [Abstract][Full Text] [Related]
29. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells. Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563 [TBL] [Abstract][Full Text] [Related]
30. Toxicological Profiling and Long-Term Effects of Bare, PEGylated- and Galacto-Oligosaccharide-Functionalized Mesoporous Silica Nanoparticles. Barguilla I; Candela-Noguera V; Oliver P; Annangi B; Díez P; Aznar E; Martínez-Máñez R; Marcos R; Hernández A; Marcos MD Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003350 [TBL] [Abstract][Full Text] [Related]
31. Fluorescein isothiocyanate-dyed mesoporous silica nanoparticles for tracking antioxidant delivery. Rashidi L; Ganji F; Vasheghani-Farahani E IET Nanobiotechnol; 2017 Jun; 11(4):454-462. PubMed ID: 28530196 [TBL] [Abstract][Full Text] [Related]
32. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery. Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885 [TBL] [Abstract][Full Text] [Related]
33. Dual-Responsive Mechanized Mesoporous Silica Nanoparticles Based on Sulfonatocalixarene Supramolecular Switches. Zhou T; Song N; Xu SH; Dong B; Yang YW Chemphyschem; 2016 Jun; 17(12):1840-5. PubMed ID: 26507946 [TBL] [Abstract][Full Text] [Related]
34. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells. Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561 [TBL] [Abstract][Full Text] [Related]
35. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release. Cui Y; Dong H; Cai X; Wang D; Li Y ACS Appl Mater Interfaces; 2012 Jun; 4(6):3177-83. PubMed ID: 22646097 [TBL] [Abstract][Full Text] [Related]
36. Loading of polymyxin B onto anionic mesoporous silica nanoparticles retains antibacterial activity and enhances biocompatibility. Gounani Z; Asadollahi MA; Meyer RL; Arpanaei A Int J Pharm; 2018 Feb; 537(1-2):148-161. PubMed ID: 29278732 [TBL] [Abstract][Full Text] [Related]
37. Comparison of different cytotoxicity assays for in vitro evaluation of mesoporous silica nanoparticles. Braun K; Stürzel CM; Biskupek J; Kaiser U; Kirchhoff F; Lindén M Toxicol In Vitro; 2018 Oct; 52():214-221. PubMed ID: 29940343 [TBL] [Abstract][Full Text] [Related]
38. Molecular Elucidation of Biological Response to Mesoporous Silica Nanoparticles in Vitro and in Vivo. Chou CC; Chen W; Hung Y; Mou CY ACS Appl Mater Interfaces; 2017 Jul; 9(27):22235-22251. PubMed ID: 28608695 [TBL] [Abstract][Full Text] [Related]
39. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy. Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638 [TBL] [Abstract][Full Text] [Related]
40. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin. Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]